Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CGN.DE Stock Summary
In the News
CGN.DE Financial details
Company Rating
Strong Buy
Market Cap
77.06B
Income
5.16B
Revenue
195.19B
Book val./share
-
Cash/share
-
Dividend
4.66
Dividend %
1.61%
Employees
70.33K
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
16
Forward P/E
-
PEG
-5.54
P/S
0.44
P/B
1.86
P/C
-
P/FCF
7.75
Quick Ratio
3.13
Current Ratio
3.13
Debt / Equity
0.67
LT Debt / Equity
0.61
-
-
EPS (TTM)
14.03
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
95.49%
EPS last 5Y
-
Revenue last 5Y
4.89%
Revenue Q/Q
4.16%
EPS Q/Q
-
-
-
-
-
SMA20
-9.62%
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
4%
ROE
12%
ROC
-0.45%
Gross Margin
100%
Oper. Margin
-33%
Profit Margin
3%
Payout
27%
Shs Outstand
292.36M
Shs Float
287.05M
-
-
-
-
Target Price
-
52W Range
221.0-319.65
52W High
-17.37%
52W Low
+19.28%
RSI
39
Rel Volume
0.06
Avg Volume
16
Volume
1
Perf Week
2.33%
Perf Month
-3.76%
Perf Quarter
-
Perf Half Y
-4.22%
-
-
-
-
Beta
0.558
-
-
Volatility
2.21%, 13.01%
Prev Close
0%
Price
263.6
Change
0.27%
CGN.DE Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 408.98 | 439.96 | 515.66 | 534.5 | 0 | |
Net income per share | 13.58 | 23.17 | 15.89 | 19.84 | 0 | |
Operating cash flow per share | 25.23 | 28.36 | 21.28 | 25.61 | 0 | |
Free cash flow per share | 22.44 | 25.36 | 17.86 | 21.78 | 0 | |
Cash per share | 14.78 | 31.54 | 17.76 | 20.21 | 0 | |
Book value per share | 120.61 | 137.87 | 139.4 | 132.77 | 0 | |
Tangible book value per share | -95.19 | -80.66 | -96.84 | -98.69 | 0 | |
Share holders equity per share | 120.61 | 137.87 | 139.4 | 132.77 | 0 | |
Interest debt per share | 103.98 | 94.13 | 103.2 | 95.64 | 0 | |
Market cap | 135.24B | 144.17B | 122.92B | 110.99B | 0 | |
Enterprise value | 168.03B | 166.91B | 151.51B | 136.16B | 23.11B | |
P/E ratio | 26.5 | 17.05 | 22.89 | 16.56 | 0 | |
Price to sales ratio | 0.88 | 0.9 | 0.71 | 0.61 | 0 | |
POCF ratio | 14.26 | 13.93 | 17.09 | 12.82 | 0 | |
PFCF ratio | 16.03 | 15.58 | 20.36 | 15.08 | 0 | |
P/B Ratio | 2.98 | 2.87 | 2.61 | 2.47 | 0 | |
PTB ratio | 2.98 | 2.87 | 2.61 | 2.47 | 0 | |
EV to sales | 1.09 | 1.04 | 0.87 | 0.75 | 0.12 | |
Enterprise value over EBITDA | -1.81 | -1.77 | -1.36 | 20.42 | -0.18 | |
EV to operating cash flow | 17.72 | 16.13 | 21.07 | 15.73 | 1.96 | |
EV to free cash flow | 19.92 | 18.03 | 25.1 | 18.5 | 2.26 | |
Earnings yield | 0.04 | 0.06 | 0.04 | 0.06 | 0 | |
Free cash flow yield | 0.06 | 0.06 | 0.05 | 0.07 | 0 | |
Debt to equity | 0.83 | 0.65 | 0.71 | 0.69 | 0.67 | |
Debt to assets | 0.24 | 0.21 | 0.22 | 0.22 | 0.2 | |
Net debt to EBITDA | -0.35 | -0.24 | -0.26 | 3.77 | -0.18 | |
Current ratio | 1.01 | 1.3 | 2.84 | 2.67 | 2.86 | |
Interest coverage | -57.4 | -67.41 | -94.93 | 3.04 | -91.24 | |
Income quality | 1.85 | 1.22 | 1.33 | 1.28 | 2.2 | |
Dividend Yield | 0.01 | 0.03 | 0.01 | 0.01 | 0 | |
Payout ratio | 0.13 | 0.58 | 0.25 | 0.21 | 0.28 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.52 | 0.51 | 0.52 | 0.54 | 0.49 | |
Capex to operating cash flow | -0.11 | -0.11 | -0.16 | -0.15 | -0.13 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.29 | -0.39 | -0.39 | -0.44 | -0.52 | |
Stock based compensation to revenue | 0 | -0.03 | 0 | 0 | 0 | |
Graham number | 191.95 | 268.12 | 223.24 | 243.43 | 0 | |
ROIC | -0.91 | -0.91 | -1.13 | 0.04 | -1.67 | |
Return on tangible assets | 0.07 | 0.11 | 0.07 | 0.1 | 0.07 | |
Graham Net | -247.33 | -220.58 | -256.34 | -223.93 | 0 | |
Working capital | 314M | 6.71B | 16.9B | 18.02B | 21.1B | |
Tangible asset value | -35.79B | -29.44B | -32.73B | -33.35B | -28.77B | |
Net current asset value | -89.02B | -76.16B | -81.61B | -70.19B | -73.98B | |
Invested capital | 0.83 | 0.65 | 0.71 | 0.69 | 0.67 | |
Average receivables | 15.9B | 16.6B | 18.74B | 21.03B | 22.82B | |
Average payables | 15.31B | 17.18B | 12.74B | 7.22B | 8.16B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 37.55 | 39.53 | 42.09 | 44.37 | 44.28 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 9.72 | 9.23 | 8.67 | 8.23 | 8.24 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.11 | 0.17 | 0.11 | 0.15 | 0.11 | |
Capex per share | -2.79 | -3 | -3.41 | -3.83 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 149.77 | 157.11 | 165.06 | 166.77 | 0 | |
Net income per share | 3.83 | 4.28 | 4.96 | 4.79 | 0 | |
Operating cash flow per share | 6.87 | 17 | 8.46 | 9.61 | 0 | |
Free cash flow per share | 5.74 | 15.62 | 7.11 | 8.24 | 0 | |
Cash per share | 22.36 | 29.92 | 35.51 | 32.45 | 0 | |
Book value per share | 146.92 | 150.49 | 154.31 | 155.38 | 0 | |
Tangible book value per share | -109.2 | -112.67 | -108.65 | -106.67 | 0 | |
Share holders equity per share | 146.92 | 150.49 | 154.31 | 155.38 | 0 | |
Interest debt per share | 102.87 | 111.26 | 112.38 | 107.14 | 0 | |
Market cap | 100.3B | 81.71B | 82.21B | 84.88B | 0 | |
Enterprise value | 125.47B | 106.32B | 105.36B | 107.52B | 23.11B | |
P/E ratio | 21.45 | 16.12 | 14.08 | 15.07 | 0 | |
Price to sales ratio | 2.19 | 1.76 | 1.69 | 1.73 | 0 | |
POCF ratio | 47.79 | 16.25 | 32.99 | 30.03 | 0 | |
PFCF ratio | 57.19 | 17.69 | 39.24 | 35.03 | 0 | |
P/B Ratio | 2.24 | 1.84 | 1.81 | 1.86 | 0 | |
PTB ratio | 2.24 | 1.84 | 1.81 | 1.86 | 0 | |
EV to sales | 2.74 | 2.29 | 2.17 | 2.19 | 0.45 | |
Enterprise value over EBITDA | 107.33 | 39.83 | -3.36 | -3.36 | -0.65 | |
EV to operating cash flow | 59.78 | 21.15 | 42.28 | 38.05 | 15.75 | |
EV to free cash flow | 71.54 | 23.01 | 50.29 | 44.37 | 20.97 | |
Earnings yield | 0.01 | 0.02 | 0.02 | 0.02 | 0 | |
Free cash flow yield | 0.02 | 0.06 | 0.03 | 0.03 | 0 | |
Debt to equity | 0.69 | 0.73 | 0.72 | 0.68 | 0.67 | |
Debt to assets | 0.22 | 0.22 | 0.22 | 0.21 | 0.2 | |
Net debt to EBITDA | 21.53 | 9.22 | -0.74 | -0.71 | -0.65 | |
Current ratio | 2.67 | 2.95 | 2.67 | 3.13 | 2.86 | |
Interest coverage | 1.34 | 5.36 | -88.51 | -89.68 | -101.37 | |
Income quality | 1.75 | 3.85 | 1.65 | 1.95 | 1.33 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0.29 | 0.29 | 0.25 | 0.26 | 0.35 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.54 | 0.53 | 0.52 | 0.52 | 0.49 | |
Capex to operating cash flow | -0.16 | -0.08 | -0.16 | -0.14 | -0.25 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -0.47 | -0.54 | -0.53 | -0.53 | -0.48 | |
Stock based compensation to revenue | 0.01 | 0 | 0 | 0 | 0 | |
Graham number | 112.49 | 120.45 | 131.19 | 129.38 | 0 | |
ROIC | 0.01 | 0.02 | -0.33 | -0.34 | -2.79 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Graham Net | -247.8 | -261.37 | -259.63 | -259.59 | 0 | |
Working capital | 18.02B | 21.06B | 21.24B | 22.83B | 21.1B | |
Tangible asset value | -33.35B | -33.32B | -32B | -31.37B | -28.77B | |
Net current asset value | -70.19B | -71.54B | -70.6B | -70.33B | -73.98B | |
Invested capital | 0.69 | 0.73 | 0.72 | 0.68 | 0.67 | |
Average receivables | 22.03B | 22.48B | 23.23B | 23.74B | 23.84B | |
Average payables | 15.66B | 7.57B | 7.72B | 7.87B | 8.11B | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 43.21 | 44.54 | 43.46 | 44.05 | 41.72 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 2.08 | 2.02 | 2.07 | 2.04 | 2.16 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | |
Capex per share | -1.13 | -1.38 | -1.35 | -1.37 | 0 |
CGN.DE Frequently Asked Questions
What is Cigna Corporation stock symbol ?
Cigna Corporation is a US stock , located in Bloomfield of Ct and trading under the symbol CGN.DE
What is Cigna Corporation stock quote today ?
Cigna Corporation stock price is $263.6 today.
Is Cigna Corporation stock public?
Yes, Cigna Corporation is a publicly traded company.